跨越千年的人与药学之“恋”(2)

参考文献：

1.

2.

3.

4.

5.

6.

7.药理学[M].第9版.

8.马延.生命世界,2013(02):84-93.

9.刘朝晖.新民周刊,2020(35):72-73.

10.郭姣, 等.药学教育,2018,34(03):1-5.

11.詹正嵩,等.实用医药杂志,2011,28(02):168-170.

12.赵晨曦,等.药学学报,2017,52(06):837-847.

13.李刚霞.中国卫生产业,2011,8(10):101.

14.赵晨曦,等.药学学报,2017,52(6):837-847.

15.肖潇,等.检验医学,2019,34(5):466-471.

16.董健等，中国执业药师, 2012, 9(9) :15-20

17.Clark M. Immunol Today. 2000 Aug;21(8):397-402.

E, et al. Antibodies (Basel). 2019 Mar 5;8(1).

19.Lu RM, et al. J Biomed Sci. 2020 Jan 2;27(1):1.

20.于雪,等.天津药学,2015,27(02):70-72.

M, et al. J Toxicol Pathol. 2015 Jul;28(3):133-9.

22.Ryman JT, et al. CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):576-588.

S, et al. Headache. 2015 Sep;55(8):1171-82.

AG and Gibbs ME. Clin Pharmacol 2018;10; 123-134

MA, et al. Drug Discov Today. 2006;11:81–88.

26.Foltz IN, et al. Circulation. 2013;127:2222–2230.

27.Hayes AR, et al. Computat Math Meth Med. 2013;2013:

28.Ogu CC, et al. Pro (Bayl Univ Med Centr). 2000; 13:421-423

SK, et al. Applied Pharmacology. Elsevier, 2011

N, et al. Eur J Cancer. 2014; 50:2020-2036

31.Zhao L, et al. Acta Pharmacologica Sinica 2012; 33:1339–1347.

32.Serra López-Matencio JM, et al. J Immunol Sci. 2018;2:4–7.

JJMA, et al. Oncologist. 2017;22:1212–1221.

MA, et al. Drug Discov Jul ;12(13-14) :540-7.

, DE, et al. Am Fam Feb 01 ;77(3) :311-9.

36.Be kker PJ, et al. J Bone Miner Res. 2004;19:1059-1066.

37.中华医学会骨质疏松和骨矿盐疾病分会.中华骨质疏松和骨矿盐疾病杂志.2020,13(6):1-10.

38.

39.

40.Imel EA, et al. Osteoporos Int. 2020 Dec;31(12):2413-2424.

S, et al. J Bone Miner Metab. 2021 Jan 2.

42.夏维波,等.中华骨质疏松和骨矿盐疾病杂志,2019,12(03):211-212.

43.艾菊青,等.天津中医药大学学报,2018,37(01):84-88.